Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017, University of Southampton
Mammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.

A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Breast is the second leading cause of cancer-related death in women, with nearly 450,000 deaths per year from the disease worldwide. However, women aged 15-39 at diagnosis have a poorer chance of surviving their cancer than older women (although survival rates for the disease are generally high).

This difference is partly due to the higher incidence of adverse tumour types that occur in , but age is an independent risk factor even after accounting for differences in tumour type and treatment.

The Southampton study - one of the largest ever undertaken into the link between genes and survival in women aged 40 or under at diagnosis - looked at which factors, other than the features of the cancer tissue, might contribute to the poorer survival rate in younger women.

Scientists discovered that variations called (SNPs) in a particular gene, ADAMTSL1, increased the risk of disease progression - but only in patients with early onset of the disease. SNPs describe locations in the genome (a person's entire genetic instructions) where a single nucleotide of the DNA sequence may vary among individuals. Studies such as this look for a link between this type of genetic variation and survival.

The collaborative study is published in the journal Nature Communications. Lead author Dr William Tapper said that the findings could eventually be used to improve the accuracy of estimates of disease progression, helping clinicians and patients to choose the most effective treatments.

"This is a significant discovery with exciting implications for the future diagnosis and treatment of early-onset ," said Dr Tapper.

"Our findings increase our understanding of the genes and pathways that are involved in , and may provide new targets for the development of novel therapies.

"In the short to medium-term, this genetic factor may be used to improve prognostic models. In the long-term, when more is known about the mechanism underlying this association and its relationship with treatment response, it may have an influence on approaches to the most effective cancer treatments."

Dr Tapper added that additional studies would be needed to fully investigate the findings and their implications.

Explore further: 'Missing DNA' could hold clue to why some get breast cancer young

More information: Latha Kadalayil et al, Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women, Nature Communications (2017). DOI: 10.1038/s41467-017-01775-y

Related Stories

'Missing DNA' could hold clue to why some get breast cancer young

May 29, 2017
A University of Otago, Christchurch, discovery of missing DNA in women who develop breast cancer at a young age could hold the key to helping them beat the disease.

Breast cancer statistics, 2017: Gap in death rates between whites, blacks closing in several states

October 3, 2017
Overall breast cancer death rates dropped 39 percent between 1989 and 2015, averting 322,600 breast cancer deaths during those 26 years. And while black women continue to have higher breast cancer death rates than whites ...

Smoking negatively impacts long-term survival after breast cancer

September 21, 2017
A new study published in JNCI Cancer Spectrum finds that smoking negatively impacts long-term survival after breast cancer. Quitting smoking after diagnosis may reduce the risk of dying from breast cancer.

Pregnancy not dangerous for women who had breast cancer

June 4, 2017
Becoming pregnant after a diagnosis of breast cancer does not raise the risk of the cancer returning, said the largest study of its kind to date, released Saturday at a major cancer conference.

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Protein to control breast cancer progression identified

July 5, 2017
Switching off a protein produced in breast cancer cells can stop cancer progression, researchers from The University of Queensland have found.

Recommended for you

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.